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ABSTRACT Lung clearance index (LCI) is the main outcome of the multiple-breath washout (MBW)
test. Current recommendations for LCI acquisition are based on low-grade evidence. The aim of this study
was to challenge those recommendations using alternative methods for LCI analysis.
Nitrogen MBW measurements from school-aged children, 20 healthy controls, 20 with cystic fibrosis
(CF) and 17 with primary ciliary dyskinesia (PCD), were analysed using 1) current algorithms (standard),
2) three alternative algorithms to detect with higher precision the end of MBW testing and 3) two
alternative algorithms to determine exhaled tracer gas concentrations. LCI values, intra-test repeatability,
and ability to discriminate between health and lung disease were compared between these methods.
The analysis methods strongly influenced LCI (mean±SD overall differences (%) between standard and
alternative analysis methods: −4.9±5.7%; range: −66–19%), but did not improve intra-test variability.
Discrimination between health and disease was comparable as areas under the receiver operator curves
were not greater than that from standard analysis.
This study supports current recommendations for LCI calculation in children. Alternative methods
influence LCI estimates and hamper comparability between MBW setups. Alternative algorithms,
whenever used, should be carefully reported.
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Introduction
Multiple-breath washout (MBW) is an increasingly acknowledged lung function test in patients with
chronic lung disease [1, 2]. In principle, MBW measures the efficiency of tracer gas clearance from the
lungs across multiple breaths. Lung clearance index (LCI) is the most commonly used MBW outcome. LCI
estimates global ventilation inhomogeneity, a biomarker of central and peripheral airway obstruction, for
example in cystic fibrosis (CF) [3, 4] and primary ciliary dyskinesia (PCD) [5, 6].
Yet MBW methodology is complex and requires signal processing and breath-by-breath analyses. A series
of mathematical algorithms are needed to transform the acquired signals into meaningful outcomes.
Systematic research on MBW analysis is scarce and it remains unclear what would constitute the most
sensible MBW analysis process. Software algorithms and LCI values differ largely between similar setups
[1, 7, 8]. This is, partially, the reason for between-centre variability in LCI values, which limits their use in
multicentre comparisons and underlines the usefulness of current reference values [1].
The current consensus statement provides several analysis recommendations [9], which are based on
low-grade evidence and often lack systematic validation. LCI is the number of functional residual capacity
(FRC) lung turnovers needed to reduce alveolar tracer-gas concentration to the cut-off of 2.5% (1/40th) of
its starting concentration, calculated as the ratio of cumulative expiratory volume (CEV) to FRC (CEV/
FRC). However, it is recommended to determine it in the first of three consecutive breaths below 2.5%.
Thus, unlike the definition, by nature LCI is not calculated directly at 2.5% but at varying concentrations
below this cut-off, depending on chance, breathing pattern and other factors. The effect of this inaccuracy
on outcome measures is unclear [9].
Another challenging issue related to the MBW test is the acquisition of the tracer gas concentration per
breath. Most of the studies across the paediatric population use the end-tidal tracer gas concentration per
breath [9]. This may be susceptible to low signal-to-noise ratio at the end of the test, introducing an error
of unknown size. Alternatively, gas concentrations can be estimated from various portions of each washout
breath. Several MBW systems use the mean concentration per breath instead, either as a default or as an
optional setting [9–11], and one study has shown significant differences in LCI calculated using the mean
or the end-tidal nitrogen concentration [11].
In this study we hypothesised that 1) algorithms that can calculate with higher precision the LCI at the
cut-off of 2.5%, and 2) algorithms that estimate the tracer gas concentration in different parts of the breath
will increase the robustness of the analysis, by reducing the intra-subject variability in LCI values.
Therefore, we used 1) three alternative algorithms to detect with higher precision the end of MBW testing
and 2) two alternate algorithms to measure exhaled tracer gas concentrations, and compared the MBW
results with those derived from the recommended analysis method [9]. Primary outcomes were changes in
LCI values, intra-test repeatability, and ability to discriminate between healthy children and children with
CF or PCD lung disease. Secondary outcomes were changes in lung volumes determining LCI, i.e. CEV
and FRC.
Methods
Study design
This is a retrospective analysis of prospectively collected data. Nitrogen (N2)MBW measurements were
obtained in school-aged healthy children and children with CF or PCD. All participants were free from
acute respiratory disease for at least 2 weeks prior to testing. For healthy controls, additional exclusion
criteria were asthma or other respiratory disease, history of prematurity, and bone, neuromuscular or
cardiac disease that could affect lung function. Measurements were performed in the University Hospital
of Bern, Bern, Switzerland for healthy controls and children with CF, and in the University Children’s
Hospital of Ruhr, Bochum, Germany for children with PCD. The study was approved by the Ethics
Committees of the Canton of Bern, Switzerland and of the Ruhr University of Bochum, Germany. We
obtained written informed consent from parents or participants older than 18 years. Some data from this
cohort have been recently published [12, 13].
N2MBW measurements
Each child performed 3–4 N2MBW according to the current consensus statement [9] using the ultrasonic
flowmeter (Exhalyzer D; Eco Medics AG, Duernten, Switzerland) and the corresponding software
(Spiroware 3.1.6; Eco Medics AG). During the test children were sitting upright, wearing a nose clip and
breathing tidally through a snorkel mouthpiece, as previously described [14].
Standard analysis of the data
We analysed the data with custom-made software (LungSim, Version 4.8.5; NM GmbH, Thalwil,
Switzerland, which is based on Matlab (The Mathworks Inc., Natick, MA, USA)) [15] using raw N2MBW
https://doi.org/10.1183/23120541.00021-2017 2
CYSTIC FIBROSIS | P. ANAGNOSTOPOULOU ET AL.
signals (A-files, Spiroware 3.1.6). Calibration, body temperature and pressure saturated correction, and
signal synchronisation were performed automatically. Re-inspired nitrogen was always subtracted to obtain
net nitrogen volume using the post-gas sampling point method. The main output parameters were LCI,
FRC and CEV. The software calculated LCIstandard according to current recommendations, i.e. end-tidal
nitrogen concentration (Cet) defined as the average value between 95% and 98% of expired volume and
LCI as the ratio of CEV to FRC (CEV/FRC) at the first of three consecutive breaths below the cut-off of
2.5% (1/40th) [9] (figure 1a).
Alternative analysis methods
We used LungSim to apply novel and currently used methods.
Linear interpolation analysis
This new algorithm was used with the aim to calculate precisely the LCI at 2.5% with a focus on the end
of the test. In order to calculate MBW outcomes directly at the 2.5% cut-off, we interpolated linearly the
Cet of the breath where LCIstandard was calculated, and the Cet of the previous breath (figure 1b). CEVlinear,
FRClinear, and LCIlinear were then calculated at the 2.5% cut-off (a detailed description of the method can
be found in the online supplementary material).
Fitting-curve analysis
This new algorithm was used with the aim to calculate precisely the LCI at 2.5% taking the whole washout
curve into account. We used the Cet per breath to fit a curve using a least squares regression model (figure 1c).
CEVfit-curve, FRCfit-curve, and LCIfit-cuve were then calculated at the time point that the fitting curve crossed
the 2.5% cut-off (see the online supplementary material).
Analysis at the first breath below the 2.5% cut-off
This new algorithm was used mostly with the aim of challenging the standard method. MBW outcomes
derived from the first breath below the 2.5% cut-off, independent of whether this was followed by two
consecutive breaths below this cut-off. The rest of the analysis was performed as in the standard analysis.
In order to prevent false LCI calculation based on small superficial breaths prior to washout completion,
we performed a visual and numerical breath quality control based on inspiratory and expiratory volumes.
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FIGURE 1 a) Overview of a nitrogen multiple-breath washout measurement in LungSim (NM GmbH); the
crosses represent the end-tidal nitrogen concentration per breath, the line indicates 2.5% of the initial
nitrogen concentration. The y-axis represents the nitrogen concentration (%) on a logarithmic scale (Cet), the
x-axis represents the cumulative expiratory volume (CEV). b) Enlargement of the end of the washout curve:
lung clearance index (LCI) is calculated at the breath after 2.5% (LCIstandard), or directly at 2.5% using the
linear interpolation method (LCIlinear). c) LCI is calculated directly at Cet=2.5% using the fitting-curve method
(LCIfit-curve).
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The system did not allow LCI calculations in breaths with inspiratory and/or expiratory volume less than
half of the mean tidal volume.
In theory, the Cet for every washout breath is progressively lower. In practice, we often see that the Cet in
the last washout breaths oscillates with values higher or lower than the cut-off of 2.5% (figure 2). We
named this phenomenon a “tracer-gas fluctuation”. Based on the change in the end of the washout
between this method and the standard method, we were able to define numerically tracer-gas fluctuations
around the cut-off of 2.5%. Thus, we compared the washout breath number where LCI was measured
(BrNr) between the standard analysis (BrNrstandard) and the analysis using the first breath below the
cut-off (BrNrfirst-breath) (ΔBrNr=BrNrstandard−BrNrfirst-breath). ΔBrNr⩾2 was a sign of fluctuation, and this
was verified by visual control of the nitrogen concentration curve (figure 2).
Analysis with alternative methods to detect expiratory tracer gas concentration
Mean expiratory nitrogen concentration
For each breath, instead of Cet, the mean nitrogen concentration (Cmean) across 65–95% of the expired
volume was used, while the rest of the analysis was performed as in the standard analysis. This algorithm
is currently in use for certain setups (figure E3) [10, 11].
Median expiratory nitrogen concentration
For each breath, the median nitrogen concentration (Cmedian) of 65–95% of the expired volume was used
(figure E3), while the rest of the analysis was performed as in the standard analysis. This algorithm can be
optionally used in a commercially available setup [10].
Statistics
Data were analysed using GraphPad Prism version 5 for Windows (GraphPad Software, San Diego, CA,
USA) and Stata (Stata Statistical Software: Release 13; StataCorp LP, College Station, TX, USA). Sample
size was estimated based on previous controlled trials using LCI as the primary outcome, and considering
the difference of one turnover as clinically significant [16, 17]. We used the paired t-test for comparisons
of MBW outcomes of the same measurements analysed with different algorithms, and the unpaired t-test
and one-way ANOVA with Tukey’s multiple comparison for the comparison of MBW outcomes between
subjects. Relative changes from the standard analysis were visualised using the Bland–Altman method [18].
The intra-subject LCI variability was defined with the coefficient of variation (CV (%)=SD/mean). We
estimated as clinically significant the difference in variability that is twice the SD of variability of the
standard analysis per group. Receiver operating characteristics (ROC) analysis was used to estimate the
ability of LCI calculated with the different methods to discriminate between health and lung disease
(children with CF or PCD). Areas under the ROC curve were compared using the Chi-squared test. A
linear regression analysis was used for associations between LCIstandard values and 1) the end of the
washout, as potentially dependent on Cmean and Cmedian; and 2) fluctuations of nitrogen concentration at
the end of the washout. A p-value<0.05 was accepted to indicate statistical significance.
Results
N2MBW measurements were performed in 20 healthy children, mean age 13.3 years (range:
7.6–15.9 years), 20 children with CF, mean age 9.9 years (4.6–16.6 years), and 17 children with PCD, mean
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FIGURE 2 Nitrogen concentration curve at the end of the washout from a nitrogen multiple-breath washout
measurement in a patient with primary ciliary dyskinesia with fluctuation around 2.5% analysed in LungSim
(NM GmbH). The crosses represent the end-tidal nitrogen concentration per breath, the line indicates 2.5% of
the initial nitrogen concentration. The y-axis represents the normalised nitrogen concentration (Cet) and the
x-axis the cumulative expiratory volume (CEV). Lung clearance index (LCI) from the first of three consecutive
breaths below the 2.5% cut-off (LCIstandard) and from the first breath below 2.5% (LCIfirst-breath) are
highlighted. LCIfirst-breath is calculated seven breaths prior to LCIstandard.
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age 11.8 years (5.1–18.1 years) (table 1). As expected, LCI in children with CF and PCD was significantly
higher compared with healthy children (p<0.001). LCI between children with CF and children with PCD
did not differ significantly.
Linear interpolation analysis
LCIlinear values were systematically lower than LCIstandard in all groups (figure 3a, table 2). Relative
mean±SD difference from LCIstandard was −1.7±1.3%, with no statistically significant differences between
groups (table 2). Intra-subject variability (CV %) in LCI was comparable between both methods (table 3).
The effect on LCI was mainly due to decreased CEVlinear values in all groups, while FRC was minimally
affected (maximum difference, FRCstandard−FRClinear=0.03 L) (table E1). The ability of this method to
discriminate between health and disease did not differ significantly from the standard analysis (figure 4a).
Fitting-curve analysis
Using the nonlinear curve-fitting method, the washout curve did not reach the standard 2.5% cut-off in six
(10%) out of 60 measurements of healthy children, and 11 (22%) out of 51 measurements of children with
PCD. LCIfit-curve values were in a nonsystematic way lower than LCIstandard in all groups (figure 3b and
table 2). Relative mean±SD difference from LCIstandard was −11.1±15.7% and varied significantly between
groups (table 2). The intra-subject variability in LCI remained unchanged in healthy and CF, but was
higher in PCD compared with the standard analysis (table 3). Using this method, the discrimination
between health and disease was poorer in comparison with the standard method (figure 4a).
TABLE 1 Demographics of the study subjects
Healthy CF PCD
Subjects n 20 20 17
Males 9 8 9
Age years 13.3±1.89 9.9±3.61 11.8±3.76
Weight kg 48.1±12.51 31.7±12.89 45.5±15.1
Weight z-score# 0.05±0.90 −0.33±0.79 0.62±1.22
Height cm 157.9±11.76 134.4±19.35 147.2±19.37
Height z-score# 0.19±1.06 −0.33±0.95 0.12±1.15
LCIstandard 7.10±0.56 10.13±2.00
¶,+ 10.12±2.21¶,+
Data are presented as mean±SD, unless otherwise stated. CF: cystic fibrosis; PCD: primary ciliary
dyskinesia; LCIstandard: lung clearance index calculated according to the current recommendations [9].
#: z-scores calculated according to Centers for Disease Control and Prevention growth charts [30];
¶: p<0.001, unpaired t-test, compared with healthy subjects; +: p=0.3, unpaired t-test between CF and PCD
groups.
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FIGURE 3 The linear interpolation analysis and the fitting-curve analysis give lower values for lung clearance
index (LCI). a) Bland–Altman plots of the absolute difference between LCIlinear and LCIstandard plotted versus
the mean of LCIlinear and LCIstandard for 20 healthy children, 20 children with cystic fibrosis (CF) and 17
children with primary ciliary dyskinesia (PCD) (one-way ANOVA, p=0.07). b) Bland-Altman plots of relative
difference between LCIfit-curve and LCIstandard plotted versus mean of LCIfit-curve and LCIstandard for 20 healthy
children, 20 children with CF and 17 children with PCD (one-way ANOVA, p<0.001).
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CEVfit-curve, but also FRCfit-curve, values were lower than standard in all groups (table E1). In the CF and
PCD groups, mean LCIfit-curve was also significantly lower than mean LCIlinear (p<0.001 for CF, p<0.0001
for PCD).
LCI at the first breath below the 2.5% cut-off
LCI from the first breath below 2.5% was lower in all groups compared with LCIstandard (table 2 and figure E4).
Relative mean±SD difference from LCIstandard was −1.8±4.3% and varied significantly between groups (table 2).
The intra-subject variability in LCI (table 3) and the ability to discriminate between health and disease
(figure 4a) were similar to the standard analysis.
At least one N2MBW measurement with fluctuations around the cut-off of 2.5% was observed in seven
(35%) out of 20 healthy children, nine (45%) out of 20 children with CF and 12 (71%) out of 17 children
with PCD (figure E5). A lower number of measurements with fluctuations were observed around the
cut-off of 5% (figure E6). The presence of fluctuations was further associated with higher LCI values in
both CF (coefficient: 0.47, R2: 0.14, p=0.003, CI: 0.16–0.77) and PCD (coefficient: 0.29, R2: 0.31, p<0.0001,
CI: 0.16–0.42) patients, but not in healthy children (coefficient: 0.15, R2: 0.05, p=0.1, CI: −0.03–0.33)
(figure E5).
Effect of mean/median nitrogen expiratory concentration on LCI values
LCImeanN2 as well as LCImedianN2 values were significantly lower compared with standard values in all
groups, but the LCI intra-subject variability was not changed (figure 5, tables 2 and 3). The relative
mean±SD difference from LCIstandard was −4.2±5.3% for LCImeanN2 and −4.1±5.2% for LCImedianN2, and
was significantly lower in healthy subjects compared with disease groups in both analyses (table 2).
TABLE 2 Lung clearance index values at 2.5% cut-off (LCI2.5) in healthy controls, children with CF and children with PCD,
calculated with the different analysis methods in LungSim, and relative difference from the LCI calculated with the standard
analysis (ΔLCI)
Analysis Healthy (n=20) CF (n=20) PCD (n=17)
Mean±SD LCI2.5 ΔLCI (95% CI) % Mean±SD LCI2.5 ΔLCI (95% CI) % Mean±SD LCI2.5 ΔLCI (95% CI) %
Standard 7.11±0.45 10.13±1.98 10.12±2.21
Linear 6.98±0.46*** −2.0 (−2.7– −1.3) 9.95±1.98*** −2.0 (−2.4– −1.5) 9.79±2.14*** −1.1 (−1.9– −0.3)
Fit-curve 6.88±0.68*** −3.6 (−6.4– 0.8) 9.16±1.56*** −9.7 (−12.4– −7.1) 8.04±1.22*** −19.7 (−29.8– −9.6)
1st breath 7.06±0.57 −0.6 (−1.2– 0.0) 9.99±1.90*** −1.4 (−2.3–0.4) 9.55±1.92*** −5.1 (−6.0– −2.0)
Cmean 6.95±0.47*** −2.5 (−3.6– −1.3) 9.56±1.60*** −5.4 (−7.2– −3.5) 9.39±1.82*** −5.1 (−7.4– −2.8)
Cmedian 6.94±0.47*** −2.5 (−3.6– −1.5) 9.61±1.60*** −4.9 (−6.7– −3.1) 9.49±2.68*** −5.6 (−7.5– −2.7)
CF: cystic fibrosis; PCD: primary ciliary dyskinesia; linear: linear interpolation method; fit-curve: fitting-curve method; 1st breath: LCI
calculated at the first breath below a cut-off; Cmean: mean expiratory nitrogen concentration; Cmedian: median expiratory nitrogen concentration.
***: p<0.001, paired t-test compared with standard analysis.
TABLE 3 Coefficient of intra-subject variation in lung clearance index at 2.5% cut-off (CVLCI) in
healthy children, children with CF and children with PCD, analysed with different methods
Analysis CVLCI %
Healthy (n=20) CF (n=20) PCD (n=17)
Standard 4.7±3.5 5.7±2.5 7.1±3.8
Linear 4.3±3.3 5.4±2.8 7.2±4.0
Fit-curve 5.1±3.2 6.0±5.3 17.6±11.0***
1st breath 4.6±3.1 5.1±2.5 5.3±3.2
Cmean 5.4±3.7 5.3±2.9 5.9±3.7
Cmedian 5.2±3.5 5.3±3.0 5.9±3.6
Data are presented as mean±SD. CF: cystic fibrosis; PCD: primary ciliary dyskinesia; linear: linear
interpolation method; fit-curve: fitting-curve method; 1st breath: LCI calculated at the first breath below a
cut-off; Cmean: mean expiratory nitrogen concentration; Cmedian: median expiratory nitrogen concentration.
***: p<0.001, paired t-test compared with standard analysis.
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Both LCImeanN2 and LCImedianN2 values were calculated earlier in the washout curve, compared with
LCIstandard (table E2). Interestingly, the higher the degree of ventilation inhomogeneity (LCI values), the
earlier the breath number in the washout curve where the LCImeanN2 is calculated, compared
with LCIstandard (coefficient: 0.66, R
2: 0.47, p<0.001, CI: 0.57–0.74). We observed similar findings
in LCImedianN2. Minimal but statistically significant differences were found between LCImeanN2 and
LCImedianN2 in the healthy (p=0.047) and CF (p=0.038) groups, but not in the PCD group (p=0.6),
although the breath number for the LCI calculation remained the same (table E2).
Discussion
In this proof-of-principle study we reported alternative methods for MBW analysis, and their influence on
MBW outcomes. We used different methods aiming to define the end of the washout with high precision,
which gave LCI values lower than the standard analysis, without improving the intra-subject variability in
LCI. Alternative ways to detect expiratory tracer gas concentration had a great influence on LCI values.
The ability to discriminate between health and disease was excellent for all methods and only declined
using the nonlinear curve-fitting method.
To our knowledge, this is the first study that reports mathematical ways to analyse LCI directly at the
cut-off. Both fitting methods influence mainly the end of the washout curve. However, they have a
principal difference. The fit-curve method is based on breath-by-breath nitrogen concentration of the
whole washout, and thus depends on the breathing pattern across the whole test. The linear interpolation
method uses only two values around the cut-off at the end of the test. This explains why LCIlinear values
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FIGURE 5 Lung clearance index (LCI) values based on the end-tidal nitrogen washout curve (LCIstandard) are
higher compared with the mean or median expiratory nitrogen curve (LCImeanN2 and LCImedianN2, respectively).
Bland–Altman plots of relative difference a) between LCImeanN2 and LCIstandard plotted versus the mean of
LCImeanN2 and LCIstandard; and b) between LCImedianN2 and LCIstandard plotted versus the mean of LCImedianN2
and LCIstandard for 20 healthy children, 20 children with cystic fibrosis (CF) and 17 children with primary ciliary
dyskinesia (PCD) (one-way ANOVA, p<0.001).
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were slightly, but systematically lower than LCIstandard, while LCIfit-curve values were more variable. The
differences found in LCI values from the different analysis methods were mainly due to differences in
CEV. FRC was less affected by the different algorithms.
Surprisingly none of the fitting methods resulted in lower intra-test variability of LCI. We speculate that
breathing pattern and sensors, as well as the time interval between the washouts [19, 20], have a greater
influence on intra-test variability. We only assessed indices based on “areas under the curve”, such as LCI.
These indices are known to be inherently less variable compared with phase III slope indices.
Our findings support the present consensus recommendation for three consecutive breaths below the 2.5%
cut-off. Intra-test variability and detection of lung disease were excellent. Consideration of three breaths at
the end of the washout prevents false early test termination. The latter may occur due to nitrogen
fluctuations around the cut-off even in healthy children. Fluctuations may relate to several factors, for
example lower signal-to-noise ratio, breathing pattern, opening of slowly ventilated compartments and
back-diffusion of tissue-nitrogen [8, 9, 21]. We assume that variable ventilation of lung compartments was
important, as the fluctuations were greater in CF and PCD. Increased back-diffusion or breathing variability
in diseased children appears counterintuitive. Serial opening of slowly ventilated lung compartments seems
to be a distinct feature in patients with abnormal ventilation distribution efficiency [8, 9].
Differences in LCI between end-expiratory and mean or median expiratory nitrogen concentrations were
small and in accordance with previous reports [11, 22]. As expected, the impact was disease-dependent.
Because phase III slopes were steeper (from visual inspection) in measurements from CF and PCD
patients, averaging expiratory nitrogen across the phase III underestimated later end-tidal nitrogen [10].
Yet intra-test variability and differentiation between health and disease were not impaired, suggesting that
averaging nitrogen across larger portions of washout breaths is appropriate.
In our study, the influence of alternative algorithms was more prominent in LCI values from patients with
CF or PCD. This is not surprising, as the uneven ventilation and the late opening of slowly ventilated
areas mostly affect the end of the test. Moreover, the part of expiration that the tracer gas concentration is
determined from is more critical in patients with CF or PCD, as mentioned earlier. Therefore, in
accordance to similar studies [23, 24], our analysis suggests that it is essential to include measurements
from subjects with lung disease in software/algorithm validation studies, as those measurements are more
sensitive to small changes in the analysis process.
The alternative algorithms proposed here can be applied to any MBW setup, as they are independent of
the tracer gas and hardware/software used. It will be interesting to investigate the influence of those
algorithms using foreign tracer gases, considering the differences in washout behaviour between nitrogen
and SF6 [8, 21].
The strengths of our study relate to a sufficiently large sample size which, for example, previously allowed
the detection of treatment effects in CF [16] or physiological phenotypes [25]. MBW testing was carried
out according to the current guidelines in the same device and recording software.
The intra-test variability in LCI values was chosen to measure the robustness of different algorithms, as
previously described [24, 26]. Despite the high quality of the recordings, intra-test variability was widely
scattered, which possibly facilitates comparison to clinical testing situations. However, according to a post
hoc power analysis, the study was underpowered to detect significant changes in intra-subject variability, as
this would require a much larger sample (n=730 with 90% power at the 0.05 level) that is non-realistic in
a clinical setting. Moreover, all tests were performed at a single time-point, so we were not able to assess
the intra-subject between-test repeatability [27].
The healthy subjects in our study were slightly older than our patients. Yet intra-test variability did not differ
and ventilation inhomogeneity indices marginally relate to body size in the age range assessed [28]. Effects
of the different analysis methods could therefore be easily assessed. We avoided mathematical extrapolation
and considered both the full washout and its end. For comparison we used clinically relevant outcomes such
as ROC curves to discriminate between health and disease. However, we did not assess the sensitivity to
capture lung function response to interventions or lung function dynamics over time. We also did not assess
the relationship with structural changes of the airways which have been described previously [29].
This methodological report has several clinical implications. We were able to show that MBW outcomes
are prone to the analysis method used, and thus it is of high priority to stick to the analysis outlined in
the current recommendations [9]. Alternative analysis methods should be clearly stated by the
manufacturers and the users. The differences in the outcomes provided here do not allow any direct
comparison of results analysed with different methods, and limit the use of normative values not only to
the same setup but additionally to the same analysis algorithms.
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Overall, the data support current recommendations to measure LCI in children. Standard LCI is
characterised by low intra-test variability and good discrimination between children with CF or PCD and
controls. However, we show that the use of different analysis algorithms may considerably influence LCI.
Reference equations should be based on appropriate normative data obtained by the same hardware and
software with appropriate settings. Transparent reporting of algorithms is necessary in both research and
clinical applications.
Conflict of interest: None declared.
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